Addiction treatment in Indiana

On any given week in Indiana, several hundred residents are hospitalized for overdose. The treatment infrastructure that could prevent most of the deaths behind those hospitalizations is distributed unevenly — 568 facilities concentrated in specific metros, thinning as you move toward the Midwest geography. This is an editorial look at who that serves and who it fails.

The Medicaid question

Indiana expanded Medicaid in 2015 under the Affordable Care Act. This single policy decision shapes access more than any other single factor. Has realistic access to Medicaid coverage for addiction treatment once enrolled. The states that expanded tend to see meaningfully higher treatment engagement; the states that did not tend to push low-income adults into the state-funded margin, where capacity runs out faster than demand.

The overdose-mortality context

The CDC puts Indiana's 2023 overdose mortality at 40.2 per 100,000. Whether that number is going up or down week-to-week matters less than where it concentrates, which is uneven: HIV outbreak tied to injection drug use required specialized integrated care

How access actually works in Indiana

The 568 facilities in Indiana are not interchangeable. Ownership structure, clinical framework, payer mix, and MAT availability vary enough that "any rehab" and "a good rehab for this person" are materially different propositions. HIV outbreak tied to injection drug use required specialized integrated care — so the search is less about proximity than about fit.

What to do next

In Indiana, the most underused resource is the PCP. Primary care has expanded its role in addiction treatment substantially since 2020 — buprenorphine prescribing, naltrexone administration, referrals into the evidence-based portion of the network — and a 30-minute PCP appointment often produces more useful direction than a 30-minute call with a treatment-center admissions counselor whose incentives are commercial.